FIELD: pharmacy.
SUBSTANCE: invention refers to chemically modified glycosaminoglycan, which is heparin or heparan sulfate with anti-factor IIa activity less than 10 IU/mg, anti-factor Xa activity less than 10 IU/mg and average molecular weight from 4.6 to 6.9 kDa.
EFFECT: invention also refers to a method for production of modified glycosaminoglycan and its medical application.
45 cl, 3 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| GLYCOSAMINOGLYCANS, DERIVATIVES OF K5 POLYSACCHARIDE, POSSESSING HIGH ANTI-COAGULANT AND ANTI-THROMBOSIS ACTIVITY AND METHOD FOR THEIR PREPARING | 2001 |
|
RU2283319C2 |
| DERIVATIVES OF POLYSACCHARIDES WITH HIGH THROMOBITIC ACTIVITY IN PLASMA | 2004 |
|
RU2361881C2 |
| LOW MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND APPLICATION THEREOF | 2007 |
|
RU2451515C2 |
| PURIFIED HEPARIN FRACTION, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION CONTAINING ON SAID | 1994 |
|
RU2133253C1 |
| METHOD FOR PREPARING MODIFIED GLYCOSAMINOGLYCANS POSSESSING ANALGESIC PROPERTY | 2005 |
|
RU2283320C1 |
| IMPROVED METHOD FOR PRODUCTION OF DALTEPARIN SODIUM | 2019 |
|
RU2783697C2 |
| EPIMERISED K5 POLYSACCHARIDE DERIVATIVES WITH HIGH SULFATION DEGREE | 2003 |
|
RU2333222C2 |
| UNSATURATED DERIVATIVES OF POLYSACCHARIDES, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2725500C1 |
| SULPHATED POLYSACCHARIDES DERIVATIVES, THEIR PRODUCTION METHOD, MODIFICATION AND APPLICATION | 2016 |
|
RU2708327C2 |
| METHOD OF OBTAINING LOW-MOLECULAR HEPARIN | 2012 |
|
RU2512768C1 |
